Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. 

Biotechnology

Systems Oncology

Spyro Mousses

Alex Lukianov

Katy Marhenke

Robert G. Petit II

Lizette Castano

Marvin O’Ketch

Andrew Matricaria

David Lee

Daniel D. Von Hoff

The Leadership Team at Systems Oncology is responsible for guiding the strategic direction of the company, overseeing financial operations, and driving clinical development initiatives. Comprised of seasoned executives with expertise in finance and clinical strategy, the team collaborates to ensure the successful advancement of innovative RNA therapeutics while addressing emerging challenges in disease treatment and drug resistance.

Leadership Team

Scientific Advisors

Research and Development

Leadership Team

About

Team members

Other teams at Systems Oncology

Scientific Advisors

Research and Development